Revolution Medicines
RVMD
RVMD
322 hedge funds and large institutions have $8.96B invested in Revolution Medicines in 2025 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 118 increasing their positions, 92 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% more capital invested
Capital invested by funds: $7.02B → $8.96B (+$1.94B)
5% more funds holding
Funds holding: 306 → 322 (+16)
0.24% more ownership
Funds ownership: 102.39% → 102.63% (+0.24%)
Holders
322
Holding in Top 10
24
Calls
$128M
Puts
$47M
Top Buyers
| 1 | +$96.9M | |
| 2 | +$42.1M | |
| 3 | +$38.9M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$33.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$30M |
Top Sellers
| 1 | -$55.4M | |
| 2 | -$39.4M | |
| 3 | -$37.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.4M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$28.9M |
